Alaunos Therapeutics (TCRT) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Alaunos Therapeutics (TCRT) over the last 15 years, with Q3 2025 value amounting to -$923.7 million.
- Alaunos Therapeutics' Retained Earnings fell 43.76% to -$923.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$923.7 million, marking a year-over-year decrease of 43.76%. This contributed to the annual value of -$920.4 million for FY2024, which is 51.09% down from last year.
- According to the latest figures from Q3 2025, Alaunos Therapeutics' Retained Earnings is -$923.7 million, which was down 43.76% from -$922.6 million recorded in Q2 2025.
- Alaunos Therapeutics' 5-year Retained Earnings high stood at -$785.7 million for Q1 2021, and its period low was -$923.7 million during Q3 2025.
- In the last 5 years, Alaunos Therapeutics' Retained Earnings had a median value of -$899.4 million in 2023 and averaged -$883.9 million.
- As far as peak fluctuations go, Alaunos Therapeutics' Retained Earnings tumbled by 1210.95% in 2021, and later crashed by 43.76% in 2025.
- Over the past 5 years, Alaunos Therapeutics' Retained Earnings (Quarter) stood at -$842.9 million in 2021, then dropped by 4.48% to -$880.6 million in 2022, then dropped by 3.99% to -$915.8 million in 2023, then fell by 0.51% to -$920.4 million in 2024, then dropped by 0.36% to -$923.7 million in 2025.
- Its Retained Earnings was -$923.7 million in Q3 2025, compared to -$922.6 million in Q2 2025 and -$921.5 million in Q1 2025.